期刊文献+

血浆胱抑素C与同型半胱氨酸联合检测在妊娠期糖尿病早期肾损害诊断中价值的观察 被引量:22

Diagnostic values of combination assay of serum cystatin C and homocysteine for early renal injury in patients with gestational diabetes mellitus
原文传递
导出
摘要 目的探讨血浆胱抑素C(Cys-C)、同型半胱氨酸(Hcy)与GDM早期肾损害的关系。方法选取GDM患者(GDM)73例、妊娠期IGT者(GIGT)89例、正常妊娠者80名及健康育龄妇女(NGT)80名,比较各组Hcy、Cys-C、Scr、BUN、尿微量白蛋白(MAU)水平。结果 GDM组Cys-C[(2.94±0.51)vs(1.72±0.37)、(1.14±0.46)mg/L]、Hcy[(22.33±5.32)vs(18.19±4.25)、(13.24±3.16)μmol/L]和MAU[(24.37±5.67)vs(21.72±3.42)、(21.55±4.28)mg/24h]水平均高于GIGT、正常妊娠组(P<0.05);相关分析显示,Hcy、Cys-C与MAU呈正相关。结论 Cys-C和Hcy联合检测对GDM早期慢性肾脏疾病诊断可能具有临床意义。 Objective To explore diagnostic values of combination assay of serum cystatin C(Cyc‐C) and homocysteine for early renal injury in patients with gestational diabetes mellitus(GDM). Methods 73 cases with GDM ,89 cases with gestational impaired glucose tolerance(GIGT group) ,80 cases of normal pregnant women and 80 healthy child bearing women (NGT group) were recruited. The clinical data were compared‐among groups. The correlations of serum Hcy and Cys‐C with Scr ,BUN and MAU were respectively analyzed. Results The patients with GDM versus normal pregnant women and NGT women had higher levels of Cys‐C[(2.94 ± 0.51) vs (1.72 ± 0.37) ,(1.14 ± 0.46)mg/L] ,of Hcy[(22.33 ± 5.32) vs(18.19±4.25),(13.24±3.16)μmol/L]andofMAU[(24.37±5.67)vs(21.72±3.42),(21.55± 4.28)mg/24 h] (P〈 0.05).The levels of Hcy ,Cys‐C and MAU were positively correlated in GIGT group. Conclusion Co‐detection of serum Cys‐C and Hcy may be used as diagnostic indicators for early renal injury in GDM patients.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2015年第8期723-725,共3页 Chinese Journal of Diabetes
关键词 糖尿病 妊娠 同型半胱氨酸 胱抑素C 肾损害 尿微量白蛋白 Diabetes, gestational Homocysteie acid (Hcy) Cystatin C (Cyc-C) Renal injures Microalbuminuira(MAU)
  • 相关文献

参考文献9

二级参考文献55

  • 1刘惠玲,江怡,陈菊萍,刘玲.彩色多普勒超声诊断早期糖尿病肾病临床价值的研究[J].上海医学影像,2006,15(4):322-324. 被引量:10
  • 2Jerums G,Panagiotopoulos S,Premaratne E,et al.Integrating albuminuria and GFR in the assessment of diabetic nephropathy.Nat Rev Nephrol,2009,5(7):397-406.
  • 3Heine GH,Sester U,Girndt M,et al.Acanthocytes in the urine:useful tool to differentiate diabetic nephropathy from glomerulonephritis? Dbetes Care,2004,27:190-194.
  • 4Granier C,Makni K,Molina L,et al.Gene and protein markers of diabetic nephropathy.Nephrol Dial Transplant,2008,23(3):792-799.
  • 5Zhang H,Jia Y,Cooper JJ,et al.Common variants in glutamine:fructose-6-phosphate amidotransferase 2(GFPT2) gene are associated with type 2 diabetes,diabetic nephropathy and increased GFPT2 mRNA levels.J Clin Endocrinol Metab,2004,89:748-755.
  • 6American Diabetes Association.Standards of Medical Care in Diabetes-2009[J].Diabetes Care,2009,32 (Suppl1):13-61.
  • 7Perkins BA,Ficociello LH,Ostrander BE,et al.Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.J Am Soc Nephrol,2007,18(4):1353-1361.
  • 8Ficociello LH,Perkins BA,Silva KH,et al.Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.Clin J Am Soc Nephrol,2007,2(3):461-469.
  • 9Kalia K,Sharma S,Mistry K.Non-enzymatic glycosylation of immunoglobu-lins in diabetic nephropathy.Clin Chim Acta,2004,347(1-2):169-176.
  • 10Lee BW,Ihm SH,Choi MG,et al.The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.Diabetes Res Clin Pract,2007,78(3):428-434.

共引文献628

同被引文献170

引证文献22

二级引证文献142

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部